Pfizer And Astellas Drugs Added To Japan MHLW's NHI Coverage List
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare released details of 11 new drugs approved at the Aug. 27 Central Social Insurance Medical Council (Chuikyo) general meeting for National Health Insurance coverage listing
You may also be interested in...
Bayer Launches Menopause Tablet Julina in Japan; First Market To Launch In World
TOKYO - Bayer HealthCare of Osaka launched its menopause and postmenopausal treatment Julina (estradiol E2) in Japan Sept. 16, making Japan the first market to launch the drug in the world, the company announced
Bayer Launches Menopause Tablet Julina in Japan; First Market To Launch In World
TOKYO - Bayer HealthCare of Osaka launched its menopause and postmenopausal treatment Julina (estradiol E2) in Japan Sept. 16, making Japan the first market to launch the drug in the world, the company announced
Japan Lists 125 New Medical Devices For NHI Coverage
TOKYO - The Central Social Insurance Medical Council (Chuikyo), the Ministry of Health, Labor and Welfare panel that decides National Health Insurance listing and prices of drugs and medical devices, approved 125 new medical devices, parts and materials for NHI coverage Aug. 27, according to the MHLW